Skip to content

The effect of topical specialized training on neuropathy in diabetic patients

Investigating the effect of topical specialized training on neuropathy in diabetic patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181006041252N16
Enrollment
50
Registered
2019-11-13
Start date
2019-04-14
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified

Interventions

Intervention 1: Intervention group: Patients in this group are given a special training protocol for 8 weeks and 5 days a week (all elbow and knee joint movements followed by thinner joints of the wri

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: FBS above 126 mg/dl or 2h blood glucose above 200 mg/dl Diabetic neuropathy Having diabetes for 4-6 years History of Metformin tablets use for at least 2 years Start medication for diabetes

Exclusion criteria

Exclusion criteria: Having autonomic neuropathy, non-diabetic neuropathy Using drugs affecting the nervous and vascular systems Having cardiac or musculoskeletal problems precludes activity

Design outcomes

Primary

MeasureTime frame
Determination of severity of diabetic neuropathy. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of the Michigan Neuropathy Screening Instrument (MNSI).;Determination of Fasting blood sugar (FBS). Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determination of Hemoglobin A1C. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.

Secondary

MeasureTime frame
Determination of the limbs blood flow. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Ankle-Brachial Index (ABI) device.;Determination of dynamic equilibrium. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of the Neuron-EMG-Micro device.;Determination of the sense of vibration. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of tuning fork device.;Determination of the sense of touch. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Rub round bottom pin, cotton or brush.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Sahebkar

Sabzevar University of Medical Sciences

Mohammad.sahebkar66@yahoo.com+98 51 4401 8337

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026